Physician profile
Amit Rajiv Chaudhari
NPI 1033606082
$5,579.25
in general payments reported to CMS, 2019-2025
13 companies · $5,160 in 2025
The $5,160 reported for 2025 was more than what 94% of Neurocritical Care providers received nationally (typical 2025 total: $95.82).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $419 · 2025: $5,160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,016 · Food and Beverage: $2,563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,015.88 |
| Food and Beverage | $2,563.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,211.87 | 2024-2025 | Pipeline, Vantage Anterior Fixation System |
| Microvention, INC. | $1,390.49 | 2025 | Web Aneurysm Embolization System, Stent, Sofia 6f-131cm Str |
| Route 92 Medical, INC. | $504.76 | 2025 | |
| Imperative Care, INC | $443.80 | 2024-2025 | Zoom Reperfusion Catheter, Zoom 88-T Large Distal Platform |
| Stryker Corporation | $308.32 | 2024-2025 | Broadway 8, Target |
| Depuy Synthes Sales INC. | $247.19 | 2025 | Cerebase |
| Penumbra, INC. | $225.16 | 2025 | Smart Coil, Penumbra System |
| Philips North America LLC | $124.23 | 2025 | Azurion 7 B20 |
| Cardiva Medical, INC. | $38.32 | 2024 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade 5f Vcs |
| Chiesi USA, INC. | $32.51 | 2024 | Kengreal, Cleviprex |
| Terumo Medical Corporation | $24.47 | 2025 | Glidesheath Slender, Angio-Seal |
| Qapel Medical INC | $14.59 | 2025 | |
| Cordis US Corp. | $13.54 | 2024 | Mynx Venous Vcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Chaudhari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.